Crucell to hold shareholders meeting on J&J offer
Biotechnology company Crucell is to hold a shareholders meeting on December 10 to discuss the takeover offer by US giant Johnson & Johnson.
Shareholder Ven Herk Groep, which has a 10% stake in Crucell, had called for the meeting. It believes the J&J offer is too low and too early. Other shareholders are also opposed to the deal.
J&J has offered €24.75 a share for Crucell, valuing the company at €1.7bn.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.
Make a donation